Seborrheic dermatitis is a skin condition that causes rashes, swelling, itchiness, and dandruff on the scalp and face. How dermatologists treat this chronic condition can depend from person to person.

Key takeaways: Malassezia yeast may not be the root cause of seborrheic dermatitis. A new study showed that Zoryve was a cosmetically pleasing treatment option for seborrheic dermatitis in diverse ...

Seborrheic dermatitis is a form of eczema that affects more than 10 million people and causes flakiness, itching, irritation, and in rare instances, hair loss. Here's what you need to know.

The US Food and Drug Administration (FDA) had previously approved ZORYVE foam 0.3% for seborrheic dermatitis in December 2023. The FDA also approved ZORYVE cream for atopic dermatitis in July 2024.

Odell Beckham Jr. opened up about his health and a recent diagnosis. The NFL star recently told Prevention he has a chronic skin condition, seborrheic dermatitis. “When I found out millions of ...

In fact, the press release cited a 2022 Harris Poll survey of more than 300 adults with seborrheic dermatitis that found 63% stated their symptoms were not severe enough to seek help.

The underlying pathophysiology of seborrheic dermatitis was once unclear, but there is now overwhelming evidence that inflammation is the driving force. Citing analyses at his institution ...

Late Friday, Arcutis’ roflumilast—now approved in both cream and foam form under the brand name Zoryve— passed muster with U.S. regulators to treat seborrheic dermatitis in patients ages 9 ...